Atherosclerosis
Volume 183, Issue 2 , Pages 199-212 , December 2005

Common polymorphisms of ATP binding cassette transporter A1, including a functional promoter polymorphism, associated with plasma high density lipoprotein cholesterol levels in Turks

  • Uğur Hodoğlugil

      Affiliations

    • Gladstone Institute of Cardiovascular Disease, 1650 Owens Street, San Francisco, CA 94158, USA
    • Cardiovascular Research Institute, University of California, San Francisco, CA, USA
    • ,
  • David W. Williamson

      Affiliations

    • Gladstone Institute of Cardiovascular Disease, 1650 Owens Street, San Francisco, CA 94158, USA
    • Graduate Program in Biological and Medical Informatics, University of California, San Francisco, CA, USA
    • ,
  • Yadong Huang

      Affiliations

    • Gladstone Institute of Cardiovascular Disease, 1650 Owens Street, San Francisco, CA 94158, USA
    • Department of Pathology, University of California, San Francisco, CA, USA
    • Cardiovascular Research Institute, University of California, San Francisco, CA, USA
    • ,
  • Robert W. Mahley

      Affiliations

    • Gladstone Institute of Cardiovascular Disease, 1650 Owens Street, San Francisco, CA 94158, USA
    • Department of Pathology, University of California, San Francisco, CA, USA
    • Department of Medicine, University of California, San Francisco, CA, USA
    • Cardiovascular Research Institute, University of California, San Francisco, CA, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 415 734 2000; fax: +1 415 355 0820.

Received 9 July 2004 ,Revised 7 February 2005 ,Accepted 1 March 2005.

References 

  1. Murray CJL , Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease study. Lancet. 1997;349:1269–1276
  2. Gordon DJ, Probstfield JL, Garrison RJ, et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation. 1989;79:8–15
  3. Jacobs DR, Mebane IL, Bangdiwala SI, Criqui MH, Tyroler HA. High density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men and women: the follow-up study of the Lipid Research Clinics Prevalence study. Am J Epidemiol. 1990;131:32–47
  4. Miller M, Rhyne J, Hamlette S, Birnbaum J, Rodriguez A. Genetics of HDL regulation in humans. Curr Opin Lipidol. 2003;14:273–279
  5. Singaraja RR, Brunham LR, Visscher H, Kastelein JJP , Hayden MR. Efflux and atherosclerosis. The clinical and biochemical impact of variations in the ABCA1 gene. Arterioscler Thromb Vasc Biol. 2003;23:1322–1332
  6. Brewer HB, Santamarina-Fojo S. Clinical significance of high-density lipoproteins and the development of atherosclerosis: focus on the role of the adenosine triphosphate-binding cassette protein A1 transporter. Am J Cardiol. 2003;92(Suppl.):10K–16K
  7. Brousseau ME. ATP-binding cassette transporter A1, fatty acids, and cholesterol absorption. Curr Opin Lipidol. 2003;14:35–40
  8. Schmitz G, Buechler C. ABCA1: Regulation, trafficking and association with heteromeric proteins. Ann Med. 2002;34:334–347
  9. Kakko S, Kelloniemi J, von Rohr P, et al. ATP-binding cassette transporter A1 locus is not a major determinant of HDL-C levels in a population at high risk for coronary heart disease. Atherosclerosis. 2003;166:285–290
  10. Wang J, Burnett JR, Near S, et al. Common and rare ABCA1 variants affecting plasma HDL cholesterol. Arterioscler Thromb Vasc Biol. 2000;20:1983–1989
  11. Harada T, Imai Y, Nojiri T, et al. A common Ile 823 Met variant of ATP-binding cassette transporter A1 gene (ABCA1) alters high density lipoprotein cholesterol level in Japanese population. Atherosclerosis. 2003;169:105–112
  12. Clee SM, Zwinderman AH, Engert JC, et al. Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease. Circulation. 2001;103:1198–1205
  13. Brousseau ME, Bodzioch M, Schaefer EJ, et al. Common variants in the gene encoding ATP-binding cassette transporter 1 in men with low HDL cholesterol levels and coronary heart disease. Atherosclerosis. 2001;154:607–611
  14. Takagi S, Iwai N, Miyazaki S, Nonogi H, Goto Y. Relationship between ABCA1 genetic variation and HDL cholesterol level in subjects with ischemic heart diseases in Japanese. Thromb Haemost. 2002;88:369–370
  15. Sandhofer AD, Iglseder B, Kaser S, et al. The common R219K variant in the ABCA–gene reduces the risk of carotid atherosclerosis independently of high density lipoprotein cholesterol concentration in younger men. Circulation. 2002;106:II–252(abstr.)
  16. Srinivasan SR, Li S, Chen W, Boerwinkle E, Berenson GS. R219K polymorphism of the ABCA1 gene and its modulation of the variations in serum high-density lipoprotein cholesterol and triglycerides related to age and adiposity in white versus black young adults. The Bogalusa heart study. Metabolism. 2003;52:930–934
  17. Frikke-Schmidt R, Nordestgaard BG, Jensen GB, Tybjærg-Hansen A. Genetic variation in ABC transporter A1 contributes to HDL cholesterol in the general population. J Clin Invest. 2004;114:1343–1353
  18. Zwarts KY, Clee SM, Zwinderman AH, et al. ABCA1 regulatory variants influence coronary artery disease independent of effects on plasma lipid levels. Clin Genet. 2002;61:115–125
  19. Tregouet D-A, Ricard S, Nicaud V, et al. In-depth haplotype analysis of ABCA1 gene polymorphisms in relation to plasma apoA1 levels and myocardial infarction. Arterioscler Thromb Vasc Biol. 2004;24:775–781
  20. Tan JH-H, Low P-S, Tan Y-S, et al. ABCA1 gene polymorphisms and their associations with coronary artery disease and plasma lipids in males from three ethnic populations in Singapore. Hum Genet. 2003;113:106–117
  21. Knoblauch H, Bauerfeind A, Toliat MR, et al. Haplotypes and SNPs in 13 lipid-relevant genes explain most of the genetic variance in high-density lipoprotein and low-density lipoprotein cholesterol. Hum Mol Genet. 2004;13:993–1004
  22. Nofer J-R, von Eckardstein A, Wiebusch H, et al. Screening for naturally occurring apolipoprotein A-I variants: apo A-I(ΔK107) is associated with low HDL-cholesterol levels in men but not in women. Hum Genet. 1995;96:177–182
  23. Couture P, Otvos JD, Cupples LA, et al. Association of the A-204C polymorphism in the cholesterol 7α-hydroxylase gene with variations in plasma low density lipoprotein cholesterol levels in the Framingham Offspring Study. J Lipid Res. 1999;40:1883–1889
  24. Ludwig EH, Mahley RW, Palaoğlu E, et al. DGAT1 promoter polymorphism associated with alterations in body mass index, high density lipoprotein levels and blood pressure in Turkish women. Clin Genet. 2002;62:68–73
  25. Bauerfeind A, Knoblauch H, Schuster H, Luft FC, Reich JG. Single nucleotide polymorphism haplotypes in the cholesteryl-ester transfer protein (CETP) gene and lipid phenotypes. Hum Hered. 2002;54:166–173
  26. Kauma H, Savolainen MJ, Heikkilä R, et al. Sex difference in the regulation of plasma high density lipoprotein cholesterol by genetic and environmental factors. Hum Genet. 1996;97:156–162
  27. Ordovas JM. Lipoprotein lipase genetic variation and gender-specific ischemic cerebrovascular disease risk. Nutr Rev. 2000;58:315–323
  28. Mahley RW, Palaoğlu KE, Atak Z, et al. Turkish Heart Study: lipids, lipoproteins, and apolipoproteins. J Lipid Res. 1995;36:839–859
  29. Mahley RW, Arşlan P, Pekcan G, et al. Plasma lipids in Turkish children: impact of puberty, socioeconomic status, and nutrition on plasma cholesterol and HDL. J Lipid Res. 2001;42:1996–2006
  30. Onat A. Risk factors and cardiovascular disease in Turkey. Atherosclerosis. 2001;156:1–10
  31. Bersot TP, Vega GL, Grundy SM, et al. Elevated hepatic lipase activity and low levels of high density lipoprotein in a normotriglyceridemic, nonobese Turkish population. J Lipid Res. 1999;40:432–438
  32. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499–502
  33. Mahley RW, Pépin J, Palaoğlu KE, et al. Low levels of high density lipoproteins in Turks, a population with elevated hepatic lipase: high density lipoprotein characterization and gender-specific effects of apolipoprotein E genotype. J Lipid Res. 2000;41:1290–1301
  34. Ludwig EH, Hopkins PN, Allen A, et al. Association of genetic variations in apolipoprotein B with hypercholesterolemia, coronary artery disease, and receptor binding of low density lipoproteins. J Lipid Res. 1997;38:1361–1373
  35. Santamarina-Fojo S, Peterson K, Knapper C, et al. Complete genomic sequence of the human ABCA1 gene: Analysis of the human and mouse ATP-binding cassette A promoter. Proc Natl Acad Sci USA. 2000;97:7987–7992
  36. Wellington CL, Walker EKY , Suarez A, et al. ABCA1 mRNA and protein distribution patterns predict multiple different roles and levels of regulation. Lab Invest. 2002;82:273–283
  37. Schneider S, Roessli D, Excoffier L. Arlequin, Version 2.000: a software for Population Genetics Data Analysis, Genetics and Biometry Laboratory, University of Geneva, Switzerland. Available at: http://lgb.unige.ch/arlequin/.
  38. Thompson EA, Deeb S, Walker D, Motulsky AG. The detection of linkage disequilibrium between closely linked markers: RFLPs at the AI-CIII apolipoprotein genes. Am J Hum Genet. 1988;42:113–124
  39. Singaraja RR, Bocher V, James ER, et al. Human ABCA1 BAC transgenic mice show increased high density lipoprotein cholesterol and apoAI-dependent efflux stimulated by an internal promoter containing liver X receptor response elements in intron 1. J Biol Chem. 2001;276:33969–33979
  40. Burchfiel CM, Laws A, Benfante R, et al. Combined effects of HDL cholesterol, triglyceride, and total cholesterol concentrations on 18-year risk of atherosclerotic disease. Circulation. 1995;92:1430–1436
  41. Mahaney MC, Blangero J, Rainwater DL, et al. A major locus influencing plasma high-density lipoprotein cholesterol levels in the San Antonio Family Heart Study: segregation and linkage analyses. Arterioscler Thromb Vasc Biol. 1995;15:1730–1739
  42. Assmann G, Schulte H. Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Am J Cardiol. 1992;70:733–737
  43. Cenarro A, Artieda M, Castillo S, et al. A common variant in the ABCA1 gene is associated with a lower risk for premature coronary heart disease in familial hypercholesterolaemia. J Med Genet. 2003;40:163–168
  44. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet. 2001;68:978–989
  45. Joyce CW, Amar MJA , Lambert G, et al. The ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL/6 and apoE-knockout mice. Proc Natl Acad Sci USA. 2002;99:407–412
  46. Pullinger CR, Hakamata H, Duchateau PN, et al. Analysis of hABC1 gene 5′ end: additional peptide sequence, promoter region, and four polymorphisms. Biochem Biophys Res Commun. 2000;271:451–455
  47. van Lennep JER , Westerveld HT, Erkelens DW, van der Wall EE. Risk factors for coronary heart disease: implications of gender. Cardiovasc Res. 2002;53:538–549
  48. LaRosa JC. Triglycerides and coronary risk in women and the elderly. Arch Intern Med. 1997;157:961–968
  49. Hergenç G, Schulte H, Assmann G, von Eckardstein A. Associations of obesity markers, insulin, and sex hormones with HDL-cholesterol levels in Turkish and German individuals. Atherosclerosis. 1999;145:147–156
  50. Katzov H, Chalmers K, Palmgren J, et al. Genetic variants of ABCA1 modify Alzheimer disease risk and quantitative traits related to β-amyloid metabolism. Hum Mutat. 2004;23:358–367
  51. Manninen V, Elo MO, Frick MH, et al. Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study. J Am Med Assoc. 1988;260:641–651

PII: S0021-9150(05)00196-6

doi: 10.1016/j.atherosclerosis.2005.03.004

Atherosclerosis
Volume 183, Issue 2 , Pages 199-212 , December 2005

Article Tools

* Image Usage & Resolution